1.
Xu C, Xiao Y, Wu Y, Bakker A, Liu Y. Impaired Osteoclastogenesis in Medication-Related Osteonecrosis and Potential Clinical Management with BMP-2. RMD [Internet]. 2024 Dec. 23 [cited 2025 May 28];1(1):5. Available from: https://w3.sciltp.com/journals/rmd/article/view/582